PLGA, PLGA-TMC and TMC-TPP nanoparticles differentially modulate the outcome of nasal vaccination by inducing tolerance or enhancing humoral immunity.

MLA

Keijzer, Chantal, et al. “PLGA, PLGA-TMC and TMC-TPP Nanoparticles Differentially Modulate the Outcome of Nasal Vaccination by Inducing Tolerance or Enhancing Humoral Immunity.” PloS One, vol. 6, no. 11, 2011, p. e26684. EBSCOhost, https://doi.org/10.1371/journal.pone.0026684.

APA

Keijzer, C., Slütter, B., van der Zee, R., Jiskoot, W., van Eden, W., & Broere, F. (2011). PLGA, PLGA-TMC and TMC-TPP nanoparticles differentially modulate the outcome of nasal vaccination by inducing tolerance or enhancing humoral immunity. PloS One, 6(11), e26684. https://doi.org/10.1371/journal.pone.0026684

Chicago

Keijzer, Chantal, Bram Slütter, Ruurd van der Zee, Wim Jiskoot, Willem van Eden, and Femke Broere. 2011. “PLGA, PLGA-TMC and TMC-TPP Nanoparticles Differentially Modulate the Outcome of Nasal Vaccination by Inducing Tolerance or Enhancing Humoral Immunity.” PloS One 6 (11): e26684. doi:10.1371/journal.pone.0026684.